Mieke Versluis

6PUBLICATIONS
9CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityImmunogenetics (incl. genetic immunology)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 15, 2020
HDAC Inhibition Increases HLA Class I Expression in Uveal Melanoma.

Zahra Souri, Aart G Jochemsen, Mieke Versluis

|Aug 21, 2019
Soluble HLA in the Aqueous Humour of Uveal Melanoma Is Associated with Unfavourable Tumour Characteristics.

Annemijn P A Wierenga, Gülçin Gezgin, Els van Beelen

|Aug 10, 2019
Do GNAQ and GNA11 Differentially Affect Inflammation and HLA Expression in Uveal Melanoma?

Christiaan van Weeghel, Annemijn P A Wierenga, Mieke Versluis

|Jul 25, 2019
Tumour Angiogenesis in Uveal Melanoma Is Related to Genetic Evolution.

Niels J Brouwer, Gülçin Gezgin, Annemijn P A Wierenga

|Jul 21, 2019
Ischemia Is Related to Tumour Genetics in Uveal Melanoma.

Niels J Brouwer, Annemijn P A Wierenga, Gülçin Gezgin

Pageof 1